Skip to main content

Advertisement

SpringerLink
Log in

Cyclooxygenase-2 Inhibitor, Celecoxib, Inhibits Leiomyoma Cell Proliferation Through the Nuclear Factor κB Pathway

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Our aim was to investigate whether celecoxib, a cyclooxygenase 2 (COX-2) inhibitor, decreases the in vitro proliferation of leiomyoma cells if the inflammatory pathway is blocked. Menstruation is an inflammation of uterus that produces cytokines and prostanoids, but the inflammatory mechanism underlying the growth of leiomyoma remains unexplained. Using in vitro cultures of leiomyoma cells obtained from 5 patients who underwent hysterectomy, cell proliferation, inflammatory signaling, transcription factors, growth factors, and extracellular matrix were examined by (4,5-dimethylthiaxol-2-yi)-2,5-diphenyltetraxolium bromide assay, immunoblotting, and quantitative polymerase chain reaction. Prostaglandin E2 was used to induce menstruation-like condition in the cells. We found that celecoxib inhibited COX-2 through the expression of nuclear factor κB in the cells. Celcoxib also decreased the gene expression of interleukin 6, tumor necrosis factor α, collagen A, fibronectin, platelet-derived growth factor, epidermal growth factor, and transforming growth factor β. In conclusion, the present study indicated that celecoxib could inhibit leiomyoma cell proliferation through blocking the inflammatory pathway that is probably one of the mechanisms underlying its pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003; 188(1):100–107.

    Article  Google Scholar 

  2. Wegienka G, Baird DD, Hertz-Picciotto I, et al. Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol. 2003;101(3):431–437.

    PubMed  Google Scholar 

  3. Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308(5728):1589–1592.

    Article  CAS  Google Scholar 

  4. Wegienka G. Are uterine leiomyoma a consequence of a chronically inflammatory immune system? Med Hypotheses. 2012; 79(2):226–231.

    Article  CAS  Google Scholar 

  5. Sikorski R, Kapec E, Zaleska W. Serum levels of proinflammatory cytokines in women with uterine myomas[in Polish]. Ginekol Pol. 2001;72(12A):1485–1488.

    CAS  PubMed  Google Scholar 

  6. Gmyrek GB, Sozanski R, Jerzak M, et al. Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2005;122(2):199–205.

    Article  CAS  Google Scholar 

  7. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci. 2003;24(2):96–102.

    Article  CAS  Google Scholar 

  8. Hull MA, Ko SC, Hawcroft G. Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? Mol Cancer Ther. 2004;3(8):1031–1039.

    CAS  PubMed  Google Scholar 

  9. Lai TY, Chen LM, Lin JY, et al. 17beta-estradiol inhibits prostaglandin E2-induced COX-2 expressions and cell migration by suppressing Akt and ERK1/2 signaling pathways in human LoVo colon cancer cells. Mol Cell Chem. 2010;342(1–2):63–70.

    CAS  Google Scholar 

  10. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994;107(4):1183–1188.

    Article  CAS  Google Scholar 

  11. Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 1996;87(5):803–809.

    Article  CAS  Google Scholar 

  12. Gee J, Lee IL, Jendiroba D, Fischer SM, Grossman HB, Sabichi AL. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer. Oncol Rep. 2006;15(2):471–477.

    CAS  PubMed  Google Scholar 

  13. Cui W, Yu CH, Hu KQ. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Clin Cancer Res. 2005;11(22):8213–8221.

    Article  CAS  Google Scholar 

  14. Ke X, Dou F, Cheng Z, et al. High expression of cyclooxygenase-2 in uterine fibroids and its correlation with cell proliferation. Eur J Obstet Gynecol Reprod Biol. 2013;168(2):199–203.

    Article  CAS  Google Scholar 

  15. Downie J, Poyser NL, Wunderlich M. Levels of prostaglandins in human endometrium during the normal menstrual cycle. J Physiol. 1974;236(2):465–472.

    Article  CAS  Google Scholar 

  16. Han M, Kim JY, Park JE, Kim JM, Lee KS. Effects of letrozole on proliferation and apoptosis in cultured leiomyoma cells treated with prostaglandin E(2). Eur J Obstet Gynecol Reprod Biol. 2008;138(1):83–88.

    Article  CAS  Google Scholar 

  17. Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update. 2004;10(3):207–220.

    Article  CAS  Google Scholar 

  18. Hoekstra AV, Sefton EC, Berry E, et al. Progestins activate the AKT pathway in leiomyoma cells and promote survival. J Clin Endocrinol Metab. 2009;94(5):1768–1774.

    Article  CAS  Google Scholar 

  19. Hardy DB, Janowski BA, Corey DR, Mendelson CR. Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression. Mol Endocrinol. 2006; 20(11):2724–2733.

    Article  CAS  Google Scholar 

  20. Ninomiya I, Nagai N, Oyama K, et al. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum. Oncol Rep. 2012;28(3):777–784.

    Article  CAS  Google Scholar 

  21. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000; 18:621–663.

    Article  CAS  Google Scholar 

  22. Catalano RD, Wilson MR, Boddy SC, Jabbour HN. Comprehensive expression analysis of prostanoid enzymes and receptors in the human endometrium across the menstrual cycle. Mol Hum Reprod. 2011;17(3):182–192.

    Article  CAS  Google Scholar 

  23. Maybin JA, Hirani N, Jabbour HN, Critchley HO. Novel roles for hypoxia and prostaglandin E2 in the regulation of IL-8 during endometrial repair. Am J Pathol. 2011;178(3): 1245–1256.

    Article  CAS  Google Scholar 

  24. Peluffo MC, Young KA, Hennebold JD, Stouffer RL. Expression and regulation of tumor necrosis factor (TNF) and TNF-receptor family members in the macaque corpus luteum during the menstrual cycle. Mol Reprod Dev. 2009;76(4):367–378.

    Article  CAS  Google Scholar 

  25. Sadowsky DW, Adams KM, Gravett MG, Witkin SS, Novy MJ. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol. 2006;195(6):1578–1589.

    Article  CAS  Google Scholar 

  26. Condon JC, Hardy DB, Kovaric K, Mendelson CR. Up-regulation of the progesterone receptor (PR)-C isoform in laboring myome-trium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function. Mol Endocrinol. 2006;20(4):764–775.

    Article  CAS  Google Scholar 

  27. Li YF, Xu XB, Chen XH, Wei G, He B, Wang JD. The nuclear factor-kappaB pathway is involved in matrix metalloproteinase-9 expression in RU486-induced endometrium breakdown in mice. Hum Reprod. 2012;27(7):2096–2106.

    Article  CAS  Google Scholar 

  28. Flake GP, Moore AB, Flagler N, et al. The natural history of uterine leiomyomas: morphometric concordance with concepts of interstitial ischemia and inanosis. Obstet Gynecol Int. 2013; 2013:285103.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Dong-A University, College of Medicine, 602-715, Busan, Korea

    Seung Bin Park MSc, Yeon Jean Cho MD & Myoungseok Han MD

  2. Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea

    Byung Chul Jee MD & Seok Hyun Kim MD

  3. Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea

    Byung Chul Jee MD & Seok Hyun Kim MD

Authors
  1. Seung Bin Park MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Byung Chul Jee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seok Hyun Kim MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yeon Jean Cho MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Myoungseok Han MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Myoungseok Han MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, S.B., Jee, B.C., Kim, S.H. et al. Cyclooxygenase-2 Inhibitor, Celecoxib, Inhibits Leiomyoma Cell Proliferation Through the Nuclear Factor κB Pathway. Reprod. Sci. 21, 1187–1195 (2014). https://doi.org/10.1177/1933719114542010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719114542010

Keywords

Search

Navigation